Masonry Blog

Donec luctus facilisis lorem, eu varius neque tincidunt in. Donec a mi purus. Maecenas ac aliquet lorem. Nunc pharetra lobortis ligula quis vehicula. Donec convallis auctor dictum. Donec congue scelerisque vehicula. Vestibulum consequat adipiscing est sagittis rutrum. Donec sodales auctor nunc eget scelerisque. Pellentesque pretium fermentum tellus, ut dapibus elit placerat ac. Praesent et metus libero. Proin auctor nibh vel rhoncus iaculis. Maecenas laoreet tortor sed tincidunt vehicula.

EOC Pharma acquires exclusive development and commercialization rights to ABI-009 in Greater China
Aadi will receive an upfront payment, regulatory and … Read More

shadow

Rolling submission of U.S. FDA New Drug Application initiated
Long-term follow-up data released at ASCO 2020 for AMPECT … Read More

shadow

Business Wire article link: Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa

 

Highlights:

Read More

shadow

Business Wire article link: Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa

 

June, … Read More

shadow

March, 7 2019, Aadi Bioscience, Inc. (Aadi), For the first time in his life, Shanahan “Shanny” Dameral, 19, has a girlfriend. … Read More

shadow

January, 3 2019, Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation, today … Read More

shadow

October, 6 2017, The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial
research grants … Read More

shadow

Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation, today announced the … Read More

shadow

Study to be conducted at major cancer centers across the US
PACIFIC PALISADES, Calif. (Nov 2, 2015) — AADi Bioscience, LLC, … Read More

shadow